Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders

Open Biology(2024)10.1098/rsob.230419Source: DataRank Database

Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders is a research paper published in Open Biology (2024). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

refsnp eudract

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: goldTopics (38)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Chris Finan ORCID,Sandesh Chopade ORCID,Stéphan Ellmerich,Martin N. Rossor ORCID,Aroon D. Hingorani ORCID

Live enrichment

PubMed:39013416 PMC:PMC11251762

UKRI/NIHR Multimorbidity Fund Mechanism and Therapeutics Research Collaborative

Grant: MR/V033867/1

Multimorbidity Mechanism and Therapeutics Research Collaborative

BHF

Grant: AA/18/6/34223

BHF

Grant: PG/18/5033837

BHF

Grant: PG/22/10989

British Heart Foundation

Grant: PG/18/50/33837

NLM NIH HHS

Grant: R01 LM010098

National Institutes of Health

Grant: 5R01LM010098-14

Bioinformatics Strategies for Genome Wide Association Studies

goldLicense: cc-by

publisherhttps://royalsocietypublishing.org/doi/pdf/10.1098/rsob.230419

publisherhttps://royalsocietypublishing.org/doi/full-xml/10.1098/rsob.230419

repositoryhttps://discovery.ucl.ac.uk/10209674/1/schmidt-et-al-genetic-evidence-for-serum-amyloid-p-component-as-a-drug-target-in-neurodegenerative-disorders.pdf

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11251762/pdf/rsob.230419.pdf

repositoryhttps://pure.amsterdamumc.nl/files/143270302/Genetic-evidence-for-serum-amyloid-p-component-as-a-drug-target-in-neurodegenerative-disorders.pdf

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

HumansLewy Body DiseaseAlzheimer DiseaseNeurodegenerative DiseasesGenetic Predisposition to DiseaseSerum Amyloid P-Componenttau ProteinsPolymorphism, Single NucleotideFemaleMaleGenome-Wide Association StudyMendelian Randomization AnalysisBiomarkers

Keywords

Alzheimer's diseaseGenome-wide Association StudyLewy Body DementiaMiridesapC-reactive Protein‌Serum Amyloid P componentLewy Body DiseaseMaleQH301-705.5tau ProteinsPolymorphism, Single NucleotideAlzheimer DiseaseHumansGenetic Predisposition to DiseaseBiology (General)ResearchNeurodegenerative DiseasesMendelian Randomization AnalysisSerum Amyloid P-Componentserum amyloid P componentFemaleBiomarkers

Sustainable Development Goals

SDG 3: 3. Good health

Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders

FAIR Checklist

Authors (7)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)